On July 17, Astellas Pharma announced that it had entered into an agreement with Frequency Therapeutics to co-develop and commercialise FX-322, a regenerative therapy to treat hearing loss.

Korro Bio and Frequency Therapeutics have completed a previously announced business combination. The new company continues with the Korro Bio name and will start trading on the Nasdaq Capital ...

Frequency Therapeutics has raised $32 million to help finance the development of its therapy for noise-induced hearing loss. The Woburn, Massachusetts-based firm specialises in small molecule ...

The S&P 500 had its second-worst day of the year to kick off the month of September, with the tech-focused Nasdaq extending its third quarter slump. Though it is likely to be lower than the ...

In-clinic RF treatments often require downtime due to redness and soreness, but at-home devices harness lower energy levels, ...

Unlock smoother, tighter skin from the comfort of your own home with CurrentBody’s RF Radio Frequency Skin Tightening Device.

Pendulum Therapeutics and BiomeSense are two biotech ... This transformation in data quality and frequency is essential for advancing our understanding of microbiome-related health and disease." ...

Introduction The effects of frequency specific microcurrent (FSM) therapy versus sham therapy in delayed onset muscle soreness (DOMS) was studied to determine whether specific frequencies on two ...

D Molecular Therapeutics reported its experimental gene therapy demonstrated a nearly 90% reduction in the need for ...

This suggests that Stoke’s strategy might effectively reduce seizure frequency while maintaining a positive ... yet the overall evidence supports his optimistic outlook for Stoke Therapeutics and ...

Recently revealed trial results for Roche's experimental weight-management drug suggest Viking Therapeutics is on the right ...